Stay updated on LBR-101 in High Frequency Episodic Migraine Clinical Trial

Sign up to get notified when there's something new on the LBR-101 in High Frequency Episodic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LBR-101 in High Frequency Episodic Migraine Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:37:34.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy or safety assessment of LBR-101 (fremanezumab) for migraine prevention in subjects with high frequency episodic migraine.
    Difference
    0.1%
    Check dated 2024-06-06T14:32:28.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying age, consent requirements, and health conditions. Previously, it only listed the dates of the last update submissions and verifications.
    Difference
    22%
    Check dated 2024-05-22T21:12:26.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:36:44.000Z thumbnail image

Stay in the know with updates to LBR-101 in High Frequency Episodic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LBR-101 in High Frequency Episodic Migraine Clinical Trial page.